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MyotoxicityAbstract Atorvastatin is considered to be one of the most commonly used of all statins antihyper-
lipidemic drugs despite the fact that there is much controversy about its safety. Its therapeutic use
becomes severely limited by the hazards of inducing myotoxicity. Curcumin is one of the safe spices
that have chemoprotection and cytoprotection effects against endogenous and exogenous noxious
stimuli. This study investigates the effect of curcumin on atorvastatin sub-chronic use - induced
myotoxicity in rats by the assessment of serum creatinine phosphokinase, lactic acid dehydrogenase,
myoglobin, troponin, potassium, creatinine and histopathological changes of skeletal, smooth and
cardiac muscles by light and electron microscope examination. Eighty adult albino rats were divided
into four groups: each group consists of twenty rats. The control group received water, the second
group received atorvastatin, third group received curcumin and the fourth group received curcumin
with atorvastatin for 90 days by gastric gavage. The prolonged use of atorvastatin induced signif-
icant abnormalities of all myotoxicity biomarkers associated with histopathological and ultrastruc-
tural changes in the different types of the muscles. Co-administration of curcumin with sub-chronic
use of atorvastatin led to an improvement in myotoxicity manifestations.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Atorvastatin is believed to be one of the statin drugs that
decreases the total cholesterol, bad cholesterol (LDL) and
triglyceride levels in the blood which cause coronary artery dis-
ease. Furthermore, atorvastatin also increases the useful
cholesterol level (HDL) that protects against coronary arteryological
2 S.S. Elshama et al.disease (Shetty et al., 2008). However, the safety of atorvas-
tatin is still controversial and its therapeutic use becomes
severely limited due to the induced myopathy that ranges from
myalgia to apoptosis and necrosis in the atorvastatin users;
yet, it was approved by FDA in December 1996 (Rodine
et al., 2010). In addition to this, there is no devised combina-
tion therapy with atorvastatin to diminish its possible side
effects such as myotoxicity, granting the fact that the combina-
tion of atorvastatin with other drugs may be used to improve
its therapeutic effect in decreasing the risk of heart diseases
(Yiannis et al., 2010).
Spices are commonly used as food additives to enhance the
taste and the flavor of the food. It has medicinal uses because
of its discovered therapeutic effects. Curcumin is considered
one of the safest spices that has been approved by the Food
and Drug Administration (FDA) in the USA, the Natural
Health Products Directorate of Canada, the Joint FAO/Table 1 Comparison between the effects of atorvastatin used alone o
myotoxicity in the rats.
Parameter Group
First M± S.D Second M± S.D
Troponin-1 (ng/ml) 0.0025 ± 0.001 0.7620 ± 0.014*
CPK (U/L) 269.1 ± 35.872 688.7 ± 86.937*
Myoglobin (ng/ml) 127.2 ± 3.792 299.0 ± 7.145*
Creatinine (mg/dl) 0.77 ± 0.114 0.94 ± 0.172*
LDH (U/L) 142.35 ± 36.552 843.4 ± 59.102*
Potassium (meq/L) 4.1 ± 0.361 4.9 ± 0.200*
Number per group: 20.
SD: standard deviation.
CPK: Creatinine phosphokinase.
LDH: lactic acid dehydrogenase.
First group (control) received distilled water.
Second group received atorvastatin only.
Third group received curcumin only.
Fourth group received curcumin with atorvastatin.
* P< 0.001 (significant difference in comparison with the first group).
** P< 0.001 (significant difference in comparison with the second grou
Table 2 Comparison between the effects of atorvastatin used alone o
the rats.
Parameter Group
First M± SD Second M± SD
Catalase 30.72 ± 1.55 11.42 ± 2.73*
Peroxidase 12.41 ± 1.21 7.69 ± 1.15*
GSH 90.22 ± 1.41 59.52 ± 3.85*
MDA 20.71 ± 0.59 54.3 ± 2.57*
Superoxide dismutase 24.31 ± 1.73 14.21 ± 0.92*
Number per group: 20.
SD: standard deviation.
GSH: Glutathione.
MDA: Malondialdehyde.
First group (control) received the distilled water.
Second group received atorvastatin only.
Third group received curcumin only.
Fourth group received curcumin with atorvastatin.
* P< 0.001 (significant difference in comparison with the first group).
** P< 0.001 (significant difference in comparison with the second grou
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and Agriculture Organization/World Health Organization
(Srivastava and Mehta, 2009). It is a yellow orange dye that
is extracted from the turmeric spice which has anti-
inflammatory, antioxidant, anti-microbial and anti-amyloid
effects (Cole et al., 2007) beside its chemoprotection and cyto-
protection effects against endogenous and exogenous noxious
stimuli, and its efficacy for treating any renal, myocardium
and nervous tissue injury (Aggarwal and Harikumar, 2009).
Recently, Curcumin has been found to possess anti-
carcinogenic activities because of its anti-proliferative effect
in multiple cancers and its effect on mutagenesis, cell cycle reg-
ulation, apoptosis and tumor growth (Wilken et al., 2011;
Aggarwal et al., 2003).
Therefore, the current study aimed to investigate the effect
of curcumin on atorvastatin sub-chronic use - induced
myotoxicity in rats by the assessment of the levels of creatininer with curcumin on Mean ± SD of different biomarkers levels of
Third M± S.D Fourth M± S.D F
0.0045 ± 0.005 0.1545 ± 0.016** 2.220
220.45 ± 9.512 335.80 ± 9.51** 398.839
127.75 ± 4.025 147.5 ± 6.022** 467.74
0.80 ± 0.121 0.64 ± 0.081** 3.4350
135.45 ± 40.066 227.5 ± 10.008** 1415.83
3.8 ± 0.125 3.9 ± 0.323** 73.537
p).
r with curcumin on Mean ± SD of oxidative stress parameters in
Third M± SD Fourth M± SD F
35.18 ± 1.42 32.77 ± 2.51** 554.411
11.89 ± 1.12 13.33 ± 1.19** 154.754
92.02 ± 3.13 91.42 ± 2.76** 437.557
21.20 ± 2.47 22.65 ± 1.94** 1.011
23.38 ± 2.57 23.53 ± 1.55** 186.217
p).
city associated with sub-chronic use of atorvastatin in rats: A histopathological
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Figure 1 (a) A photomicrograph of longitudinal section in the control rat extensor digitorum longus muscle shows normal non
branching muscle fibers (F) and multiple elongated vesicular peripheral nuclei (n). (b) A photomicrograph of longitudinal section in the
second group rat extensor digitorum longus muscle shows degenerated muscle fibers (d) with myofibers splitting (s) and cellular infiltration
(I), pyknotic nuclei (p) and the remnants of the degenerated nuclei (f). (c) A photomicrograph of longitudinal section in the third group rat
extensor digitorum longus muscle shows non branching muscle fibers (F) and multiple elongated vesicular peripheral nuclei (n). (d) A
photomicrograph of longitudinal section in the fourth group rat extensor digitorum longus muscle shows nearly normal appearance of
intact muscle fibers (F) and multiple nuclei (n).
Curcumin modulates myotoxicity associated with use of atorvastatin 3phosphokinase, lactic acid dehydrogenase, troponin I, myo-
globin, potassium, creatinine, oxidative stress parameters and
an evaluation for morphological and ultra-structural changes
in cardiac, diaphragm and extensor digitorum longus muscles.
2. Material and methods
Eighty healthy adult albino rats weighing 200–300 g were
obtained from the animal house of King Abdel Aziz
University-Jeddah. Rats were exposed to 12 h day and night
cycles and were fed with water and the standard rat pellets dur-
ing the experimental period. They were divided into the four
groups: each group comprising of twenty rats. The first control
group received distilled water (0.1 ml) while the second group
received 50 mg/kg/day of atorvastatin (1% of LD50 ‘‘5000 mg/
kg”), dissolved in distilled water (Ronald et al., 2009). The
third group received 200–300 mg/kg/day of curcumin,
dissolved in distilled water (Farombi et al., 2008) while the
fourth group received 50 mg/kg/day of atorvastatin, dissolved
in distilled water with 200–300 mg/kg/day of curcumin,
dissolved in distilled water. The daily administration of the
distilled water, atorvastatin and curcumin was done by the
gastric gavage for 90 days. The atorvastatin was available in
40 mg tablet form that was manufactured by Egyptian Interna-
tional Pharmaceutical Industries Co. (E.I.P.ICO.), 10th of
Ramadan City, Egypt, while Curcumin was purchased from
Sigma Chemical Co.Please cite this article in press as: Elshama, S.S. et al., Curcumin modulates myotoxi
and biochemical analysis. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/102.1. Blood sample collection
On the last day of the experiment, the rats were anesthetized by
diethyl ether. The blood samples were collected from the orbi-
tal sinus, using the covered test tubes. It was then left at room
temperature for 15–30 min to clot. The samples were cen-
trifuged at 2000 rpm at 4 C for 10 min to remove the clot
and to separate the serum sample that was stored at 20 C
until the assay. Measurements of troponin I and creatinine
phosphokinase were done using an Elecsys analyzer by the tro-
ponin I STAT third generation and creatinine phosphokinase
STAT methods (Roche Diagnostics, Tutzing, Germany).
These assays were based on electrochemiluminescence
immunoassay (ECLIA) technology using two mouse mono-
clonal antibodies in a sandwich format. It was a two step
assay. They were done on Elecsys 1010 and 2010 immunoassay
analyzers according to the manufacturer’s instructions (Roche
Diagnostics, Tutzing, Germany). Myoglobin concentrations
were determined using the respective Stratus fluorometric
enzyme immunoassay (Dade Behring, Newark, Delaware,
USA) (Wu et al., 1999). Serum creatinine level was determined
by the routine colorimetric methods using the commercial kits
and quantified on clinical biochemistry autoanalyzer
(Alexander and Griffith, 1992). Determination of the serum
level of lactic acid dehydrogenase and potassium was per-
formed by standard spectrophotometric analysis by using
diagnostic kits (McKenzie, 2010).city associated with sub-chronic use of atorvastatin in rats: A histopathological
.1016/j.jsps.2016.10.003
Figure 2 (a) A photomicrograph of longitudinal section in the control rat extensor digitorum longus muscle shows normal distribution
of blue stained collagen fibers around non branching muscle fibers (F). (b) A photomicrograph of longitudinal section in the second group
rat extensor digitorum longus muscle shows excessive blue collagen fibers around the splitting muscle fibers (s). (c) A photomicrograph of
longitudinal section in the third group rat extensor digitorum longus muscle shows few collagen muscle fibers (F). (d) A photomicrograph
of longitudinal section in the fourth group rat extensor digitorum longus muscle shows nearly normal few collagen muscle fibers (F).
4 S.S. Elshama et al.2.2. Histopathological studies
After 24 h, following the last administration of atorvastatin
and curcumin, the rats were sacrificed after being excessively
anesthetized. Tissue samples of the extensor digitorum longus
muscle, cardiac muscle and diaphragm were dissected from the
rats of the four groups and then it was fixed in 10% neutral
buffered formalin. The fixed specimens were trimmed, washed
and dehydrated in ascending grades of alcohol, cleared in
xylene, embedded in paraffin, sectioned at 4–6 lm thickness
and stained by Mallory stain, hematoxylin and eosin. The
muscular histological slides were examined and scored under
a light microscope, by a blinded pathologist, to quantify the
experimental groups for the extent of muscular histopatholog-
ical changes for each muscle-damaged parameter (myofibers
degeneration, cell infiltration, pyknotic nuclei and collagen
fibers distribution). This was done by using a scoring scale of
0 to 2 for each parameter that represented normal conditions
(0), moderate damages (1) and severe muscular damages (2).
Three photographs were taken of the three different parts of
each muscle sample, and analyzed individually to quantify
each muscular histopathological parameter (Bancroft and
Gamble, 2002).
Ultrastructure studies were performed by using the trans-
mission electron microscope, and the tissue specimens of the
muscles were prepared by soaking and fixating the specimens
in 2.7% glutaraldehyde solution at 0.1 M phosphate buffer
for 1.5 h at 4 C. It was then washed in 0.15 M phosphate buf-
fer (pH 7.2) and post-fixed in 2% osmic acid solution at
0.15 M phosphate buffer for one hour at 4 C. Dehydration
was done by using acetone and then by the inclusion whichPlease cite this article in press as: Elshama, S.S. et al., Curcumin modulates myotoxi
and biochemical analysis. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10occurred in the epoxy soaked resin Epon 812. The blocks were
cut with an ultramicrotome type LKB at 70 nm thickness. The
sections were differentiated with the solutions of the uranyl
acetate and lead citrate for the analysis by an electron micro-
scope (Graham and Orenstein, 2007).
2.3. Tissue preparation
500 mg of muscular tissues were homogenized in 4 ml of buffer
solution of phosphate buffered saline at PH 7.4 whereby the
homogenates were centrifuged at 10.000g for 15 min at 4 C.
The resultant supernatant was used for oxidative stress param-
eters assay such as malondialdehyde, catalase, superoxide dis-
mutase, glutathione peroxidase and glutathione (Davalos
et al., 2003).
2.4. Statistical analysis
Statistical analysis was performed using SPSS version 17. The
data were expressed as a mean + SD and the analysis was per-
formed by using one-way ANOVA and post hoc multiple com-
parison tests (TUKEY) to investigate the difference between
the biomarker levels among the different groups where the P
value of 0.05 was considered statistically significant.
2.5. Ethical considerations
The most appropriate animal species were chosen for this
research. Promotion of high standard care and animal well-
being was exercised at all times. An appropriate sample sizecity associated with sub-chronic use of atorvastatin in rats: A histopathological
.1016/j.jsps.2016.10.003
Figure 3 (a) An electron micrograph of longitudinal section in the control rat extensor digitorum longus muscle shows normal
arrangement of myofibrils (F) with light and dark bands. Sarcomeres are found between two successive Z lines (Z) with oval nucleus (N)
under the sarcolemma and subsarcolemmal mitochondria (sm), and intermyofibrillar mitochondria (im). (b) An electron micrograph of
longitudinal section in the second group rat extensor digitorum longus muscle shows disorganization and degeneration of myofibrils (LF),
marked aggregation of mitochondria in subsarcolemmal space (sm) and intermyofibrillar space (im) with vacuolated mitochondria (vm) in
the intermyofibrillar space, pyknotic nucleus (N). Disruption of Z line (Z) and loss of Z line (LZ). (c) An electron micrograph of
longitudinal section in the third group rat extensor digitorum longus muscle shows myofibrils (F), sarcomeres between two successive Z
lines (Z), an oval nucleus (N) with subsarcolemmal mitochondria (sm) and intermyofibrillar mitochondria (im). (d) An electron
micrograph of longitudinal section in the fourth group rat extensor digitorum longus muscle shows nearly normal appearance of
myofibrils (F) and sarcomeres in-between two successive Z lines (Z) with normal oval nucleus (N), subsarcolemmal mitochondria (sm) and
intermyofibrillar mitochondria (im).
Curcumin modulates myotoxicity associated with use of atorvastatin 5of animals for the experiment was calculated for using the few-
est number of animals to obtain the valid results statistically.
Painful procedures were performed under anesthesia to avoid
any distress and pain that could be inflicted on the animals.
The rats were sacrificed after being excessively anesthetized
via ether. Our standards of animal care and administration
are consistent with the requirements and standards of interna-
tional laws and regulations.
3. Results
3.1. Biochemical findings
Table 1 represents mean ± SD values of biochemical markers
in the rats. Mean ± SD values of Troponin I in the control
group which received distilled water, the second group whichPlease cite this article in press as: Elshama, S.S. et al., Curcumin modulates myotoxi
and biochemical analysis. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10received atorvastatin only, the third group which received cur-
cumin, the fourth group that received curcumin with atorvas-
tatin were 0.0025 ± .001; 0.7620 ± 0.014; 0.0045 ± 0.005 and
0.1545 ± 0.016 respectively. Value of F which indicates the
difference between groups, was 2.220 with statistically signifi-
cant at P< 0.001. Mean ± SD values of Creatinine phospho-
kinase (CPK) in the control, second, third and the fourth
groups were 269.1 ± 35.872; 688.7 ± 86.937; 220.45 ± 9.512
and 335.80 ± 9.51 respectively. Value of F which indicates
the difference between groups, was 398.839 and statistically
significant whereas p< 0.001. Mean ± SD values of Myo-
globin in the control, second, third and the fourth groups were
127.2 ± 3.792; 299.0 ± 7.145; 127.75 ± 4.025 and 147.5
± 6.022 respectively. Value of F which indicates the difference
between groups, was 467.74 and statistically significant
whereas p< 0.001. Mean ± SD values of creatinine in thecity associated with sub-chronic use of atorvastatin in rats: A histopathological
.1016/j.jsps.2016.10.003
Figure 4 (a) A photomicrograph of longitudinal section in the control rat diaphragm shows normal muscle fibers (F) and multiple
vesicular nuclei (n). (b) A photomicrograph of longitudinal section in the second group rat diaphragm shows degenerated muscle fibers
(d), myofibers splitting (s), pyknotic nuclei (p) and the remnants of the degenerated nuclei (f). (c) A photomicrograph of longitudinal
section in the third group rat diaphragm shows normal muscle fibers (F) and multiple vesicular peripheral nuclei (n). (d) A
photomicrograph of longitudinal section in the fourth group rat diaphragm shows nearly normal appearance of the intact muscle fibers
(F) and multiple vesicular nuclei (n).
Figure 5 (a) A photomicrograph of longitudinal section in the control rat diaphragm shows normal distribution of blue stained collagen
fibers around the muscle fibers (F) with many elongated peripheral nuclei (n). (b) A photomicrograph of longitudinal section in the second
group rat diaphragm shows excessive blue collagen fibers with blood vessels congestion (c). (c) A photomicrograph of longitudinal section
in the third group rat diaphragm shows few collagen fibers (F). (d) A photomicrograph of longitudinal section in the fourth group rat
diaphragm shows nearly normal few collagen fibers (F).
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Figure 6 (a) An electron micrograph of longitudinal section in the control rat diaphragm shows normal myofibrils (F) and sarcomeres,
two successive Z lines (Z), oval nucleus (N) under the sarcolemma, subsarcolemmal mitochondria (sm) and intermyofibrillar mitochondria
(im). (b) An electron micrograph of longitudinal section in the second group rat diaphragm shows marked degeneration of myofibrils (LF)
with marked aggregation of mitochondria in subsarcolemmal space (sm) and inter myofibrillar space (im) with pyknotic nucleus (N) and Z
line loss (LZ). (c) An electron micrograph of longitudinal section in the third group rat diaphragm shows normal myofibrils (F), oval
nucleus (N) with mitochondria (m) and sarcomeres in-between two successive Z lines (Z). (d) An electron micrograph of longitudinal
section in the fourth group rat diaphragm shows nearly normal appearance of myofibrils (F), sarcomeres, oval nucleus (N), mitochondria
(m) with two successive Z lines (Z).
Curcumin modulates myotoxicity associated with use of atorvastatin 7control, second, third and the fourth groups were 0.94
± 0.172, 0.77 ± 0.114, 0.95 ± 0.021 and 0.64 ± 0.081 respec-
tively. The value of F, which indicates the difference between
groups, was 3.4550 and statistically significant whereas
p< 0.001. Mean ± SD values of lactic acid dehydrogenase
(LDH) in the control, second, third and the fourth groups were
142.35 ± 36.552, 843.4 ± 59.102, 135.45 ± 40.066 and 227.5
± 10.008 respectively. The value of F which indicates the dif-
ference between groups, was 1415.83 and the statistically sig-
nificant at p< 0.001. Mean ± SD values of potassium (K)
in the control, second, third and the fourth groups were 4.1
± 0.361, 4.9 ± 0.200, 3.8 ± 0.125 and 3.9 ± 0.323 respec-
tively. The value of F which indicates the difference between
groups, was 73.537 while statistically significant was at
p< 0.001.
3.2. Oxidative stress parameters
Table 2 shows that there is a statistically significant decrease in
the values of catalase, peroxidase, glutathione and superoxide
dismutase in the second group (atorvastatin) in comparisonPlease cite this article in press as: Elshama, S.S. et al., Curcumin modulates myotoxi
and biochemical analysis. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10with the control group, while these values are increased statis-
tically significantly in the fourth group (atorvastatin with cur-
cumin) in comparison with the second group (atorvastatin).
Conversely, the value of malondialdehyde (MDA) is increased
statistically significantly in the second group (atorvastatin) in
comparison with the control group and then it is decreased sta-
tistically significantly in the fourth group (atorvastatin with
curcumin) in comparison with the second group (atorvastatin).
3.3. Histopathological findings
3.3.1. Skeletal muscle (extensor digitorum longus) by the light
microscope
Examination of longitudinal section of extensor digitorum
longus muscle in the rats of the first control group showed nor-
mal structure (Fig. 1a) with normal collagen fiber distribution
in endomysium and around the blood vessels (Fig. 2a). The
extensor digitorum longus muscle in the rats of the second
group which received atorvastatin only, showed splitting myo-
fibers with fragmentation of its sarcoplasm, cellular infiltra-
tion, dense central nuclei and necrotic nuclei remnantscity associated with sub-chronic use of atorvastatin in rats: A histopathological
.1016/j.jsps.2016.10.003
Figure 7 (a) A photomicrograph of transverse section in the control rat cardiac muscle shows normal branching and anastomosis muscle
fibers (B), acidophilic sarcoplasm and central elongated vesicular nuclei (n). (b) A photomicrograph of transverse section in the second
group rat cardiac muscle shows marked degeneration of fibers (d), acidophilic sarcoplasm with huge number of pyknotic nuclei (p) and
vacuoles (v) with blood vessels congestion (c). (c) A photomicrograph of transverse section in the third group rat cardiac muscle shows
normal non branching muscle fibers (B), acidophilic sarcoplasm and central elongated vesicular nuclei (n). (d) A photomicrograph of
transverse section in the fourth group rat cardiac muscle shows nearly intact branching and anastomosis muscle fibers (B), acidophilic
sarcoplasm and central elongated vesicular nuclei (n).
8 S.S. Elshama et al.(Fig. 1b) with excessive collagen fibers around the affected
myofibers (Fig. 2b). Longitudinal section of extensor digito-
rum longus muscle in the rats of the third group which received
curcumin showed normal cylindrical, parallel and non-
branching muscle fiber bundles and multiple peripheral nuclei
(Fig. 1c) with few collagen fibers in endomysium and around
the blood vessels (Fig. 2c). The extensor digitorum longus
muscle of the fourth group rats that received curcumin with
atorvastatin showed injury improvement and normal appear-
ance of muscle fibers simulating the control and third group
showed evidence of small areas of cellular infiltration (Fig. 1d)
and few collagen fibers in the endomysium (Fig. 2d).
3.3.2. Skeletal muscle (extensor digitorum longus) by the
transmission electron microscope
The ultrastructure of the extensor digitorum longus muscle in
the rats of the first control group showed normal sarcomeres,
sarcolemma, oval nuclei and mitochondria (Fig. 3a), and the
extensor digitorum longus muscle in the rats of the second
group which received atorvastatin only, showed marked accu-
mulation of mitochondria in the subsarcolemmal and intermy-
ofibrillar spaces with unsystematic and degenerated parts of
myofibrils with the partial loss of myofilaments and vacuola-
tion in mitochondria (Fig. 3b). The ultrastructure of the exten-
sor digitorum longus muscle in the rats of the third group
which received curcumin showed the normal appearance of
the myofibril arrangement parallel to the long axis with normal
sarcomeres, oval nuclei and mitochondria in subsarcolemmal
area. (Fig. 3c) The extensor digitorum longus muscle of thePlease cite this article in press as: Elshama, S.S. et al., Curcumin modulates myotoxi
and biochemical analysis. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10fourth group of rats that received curcumin with atorvastatin,
displayed approximately the same ultrastructure of the first
and third groups. The sarcomeres, nuclei and mitochondria
were approximately normal (Fig. 3d) for these groups.
3.3.3. Smooth muscle (diaphragm) by the light microscope
Examination of longitudinal section of diaphragm in the rats
of the first control group showed normal structural appearance
(Fig. 4a) with normal collagen fibers distribution in the con-
nective tissues (Fig. 5a). But diaphragm in the rats of the sec-
ond group which received atorvastatin only, showed splitting
myofibers, focal areas of cellular infiltration, sarcoplasm frag-
mentation and pyknotic nuclei (Fig. 4b) with excessive colla-
gen fibers distribution (Fig. 5b). Longitudinal section of the
diaphragm in the rats of the third group which received cur-
cumin showed completely normal muscles fibers (Fig. 4c) with
few collagen fibers in connective tissue (Fig. 5c). The dia-
phragm of the fourth group rats that received curcumin with
atorvastatin showed an almost near to normal appearance of
muscle fibers simulating the control and third group with rare
areas of cellular infiltration (Fig. 4d) and few collagen fibers
(Fig. 5d).
3.3.4. Smooth muscle (diaphragm) by the transmission electron
microscope
The ultrastructure of diaphragm in the rats of the first control
group showed normal appearance (Fig. 6a). But diaphragm in
the rats of the second group which received atorvastatin only,city associated with sub-chronic use of atorvastatin in rats: A histopathological
.1016/j.jsps.2016.10.003
Figure 8 (a) A photomicrograph of transverse section in the control rat cardiac muscle shows normal distribution of collagen fibers (F).
(b) A photomicrograph of transverse section in the second group rat cardiac muscle shows excess collagen fibers, cardiac muscle fibers
degeneration (d), pyknotic nuclei (p), vacuoles (v) and blood vessels congestion. (c) A photomicrograph of transverse section in the third
group rat cardiac muscle shows few collagen muscle fibers (F). (d) A photomicrograph of transverse section in the fourth group rat cardiac
muscle shows nearly normal few collagen muscle fibers (F).
Curcumin modulates myotoxicity associated with use of atorvastatin 9showed marked abnormal ultrastructures such as mitochon-
dria with degenerated parts of myofibrils (Fig. 6b). The ultra-
structure of diaphragm in the rats of the third group which
received curcumin showed normal appearance of myofibrils,
sarcomeres, nuclei and mitochondria (Fig. 6c) while dia-
phragm of the fourth group rats that received curcumin with
atorvastatin showed nearly the same ultrastructure of the first
group where sarcomeres and nuclei were approximately nor-
mal with a few mitochondria in the subsarcolemmal area
(Fig. 6d).
3.3.5. Cardiac muscle by the light microscope
Examination of cardiac muscle in the rats of the first control
group showed normal appearance of muscle fibers (Fig. 7a)
with normal few collagen fibers (Fig. 8a). But cardiac muscle
in the rats of the second group which received atorvastatin
only, showed noticeable loss of architecture, cardiomyocytes
shrinkage and vacuolated cytoplasm with small fragmented
pyknotic nuclei (Fig. 7b) with excessive collagen fibers
(Fig. 8b). Transverse section of cardiac muscle in the rats of
the third group which received curcumin showed entirely nor-
mal branching and anastomosis cardiac muscle fibers (Fig. 7c)
with little collagen muscle fibers (Fig. 8c). Cardiac muscles of
the fourth group rats that received curcumin with atorvastatin
showed close to normal appearance of branching and anasto-
mosis cardiac muscle fibers simulating the control and third
groups (Fig. 7d) and normal few collagen fibers (Fig. 8d).Please cite this article in press as: Elshama, S.S. et al., Curcumin modulates myotoxi
and biochemical analysis. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/103.3.6. Cardiac muscle by the transmission electron microscope
The ultrastructure of cardiac muscle in the rats of the first con-
trol group showed normal appearance (Fig. 9a). But cardiac
muscle in the rats of the second group which received atorvas-
tatin only, showed significant abnormal mitochondria with
pyknotic nucleus and myofibrils degeneration with vacuoles
in the cytoplasm (Fig. 9b). The ultrastructure of cardiac mus-
cle in the rats of the third group which received curcumin
showed normal appearance of ultrastructures (Fig. 9c) while
cardiac muscle of the fourth group rats that received curcumin
with atorvastatin showed near to normal appearance similar to
the first and third group whereas ultrastructures were approx-
imately normal with numerous mitochondria in the subsar-
colemmal area (Fig. 9d).
3.3.7. Quantification of histopathological changes in the different
muscles of rats
Table 3 shows the quantification of histopathological changes
in the different muscles of rats that were stained by the Mal-
lory stain, hematoxylin and eosin where a statistically signifi-
cant difference in the overall histopathological parameters of
the muscle damage (myofibers degeneration, cell infiltration,
pyknotic nuclei and collagen fibers distribution) was observed
in the second group (atorvastatin) in comparison with the con-
trol group and in the fourth group (atorvastatin and curcumin)
in comparison with the second group.city associated with sub-chronic use of atorvastatin in rats: A histopathological
.1016/j.jsps.2016.10.003
Figure 9 (a) An electron micrograph of transverse section in the control rat cardiac muscle shows normal myofibrils (F) with sarcomeres
in-between two successive Z lines (Z), oval nucleus (N) under the sarcolemma with numerous mitochondria (m), and the reticular fibrils
between the two cells (r). (b) An electron micrograph of transverse section in the second group rat cardiac muscle shows degeneration of
myofibrils (LF), marked aggregation of mitochondria in subsarcolemmal space (sm) and intermyofibrillar space (im) with vacuolation (v),
pyknotic nucleus (N) and Z line (LZ) disruption. (c) An electron micrograph of transverse section in the third group rat cardiac muscle
shows myofibrils (F), and sarcomeres, two successive Z lines (Z), an oval elongated nucleus (N) with numerous mitochondria (m) and the
reticular fibers in-between the two cells (r). (d) An electron micrograph of transverse section in the fourth group rat cardiac muscle shows
nearly normal myofibrils (F) and sarcomeres within two successive Z lines (Z) with normal oval nucleus (N), numerous mitochondria (m)
and the reticular fibers in-between the two cells (r).
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Myotoxicity is a common atorvastatin adverse effect which
has been observed in the recent years. This study evaluates
the sub-chronic use of atorvastatin induced myotoxicity
and assesses the curcumin effect on the modulation of ator-
vastatin toxicity on the different types of the muscles in rats.
Our results showed a statistically significant increase in the
levels of myotoxicity biomarkers in the second group which
received atorvastatin only. The rise of creatinine phosphoki-
nase levels is a sign of myositis and the constant biomarker
for any muscle affliction according to Phillips et al., 2002
and Chapman and Carrie, 2005; it is the key biomarker of
the myopathy diagnosis in the skeletal and cardiac muscles
because it generates adenosine triphosphate via adenosine
diphosphate phosphorylation where its level is increased after
the muscle cell membrane damage, with the subsequent leak-
age into the circulation according to Westwood et al. (2005),Please cite this article in press as: Elshama, S.S. et al., Curcumin modulates myotoxi
and biochemical analysis. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10in agreement with Jeremias and Gibson, 2005 and O’Brien,
2008 that showed that troponin I and creatinine phosphoki-
nase are highly specific for myocardium and the gold standard
for acute myocardial damage detection. Furthermore,
Thompson et al. (2003) showed that the significant increase
of creatinine phosphokinase, lactic acid dehydrogenase and
myoglobin depends mainly on the degree of muscle damage
that may lead to myoglobinuria and renal failure which causes
an increase in the levels of creatinine and potassium that may
also be attributed to impairment in Na-K channel causing irre-
versible cell damage.
The present study demonstrated histopathological and
ultrastructural changes in the different types of muscles of
the second group (atorvastatin only) such as myofibrils degen-
eration, partial loss of myofilaments, sarcoplasm fragmenta-
tion, cellular infiltration, abnormal aggregation of
mitochondria in the subsarcolemmal and intermyofibrillar
spaces, vacuolation in mitochondria and cytoplasm, pyknoticcity associated with sub-chronic use of atorvastatin in rats: A histopathological
.1016/j.jsps.2016.10.003
Table 3 Comparison between the effects of atorvastatin used alone or with curcumin on the rats’ muscles histopathological
parameters.
Parameter Group
First M± SD Second M± SD Third M± SD Fourth M± SD
Myofibers degeneration 0.1 ± 0.2 2.6 ± 0.2* 0.2 ± 0.5 0.4 ± 0.1**
Pyknotic nuclei 0.1 ± 0.7 2.2 ± 0.8* 0.2 ± 0.3 0.4 ± 0.5**
Cell infiltration 0.1 ± 0.7 3.1 ± 0.2* 0.1 ± 0.2 0.3 ± 0.4**
Collagen fibers distribution 0.1 ± 0.1 4.2 ± 0.5* 0.3 ± 0.3 0.4 ± 0.1**
Total score 0.4 ± 0.2 11.11 ± 0.2* 0.8 ± 0.1 0.15 ± 0.1**
Number per group: 20.
M± SD: Mean ± Standard deviation.
First group (control) received the distilled water.
Second group received atorvastatin only.
Third group received curcumin only.
Fourth group received curcumin with atorvastatin.
* P< 0.001 (significant difference in comparison with the first group).
** P< 0.001 (significant difference in comparison with the second group).
Curcumin modulates myotoxicity associated with use of atorvastatin 11nucleus and excessive collagen fibers distribution. Our results
are consistent with those of Radcliffe and Campbell (2008),
that are of the referred histological changes which are often
nonspecific despite the vacuolation which is considered a char-
acteristic morphological abnormality finding in atorvastatin-
induced myotoxicity in the animals and the human muscles
leading to an intracellular membrane vesicle transport distur-
bance in the myofibers (Bergman et al., 2003). There are many
mechanisms that explain atorvastatin induced myotoxicity
(Urso et al., 2005). This experiment showed that the mecha-
nism may be due to the atorvastatin effect on the gene expres-
sion via transcription and protein degradation by the ubiquitin
proteasome pathway while Pierno et al. (2009) and his col-
leagues referred to apoptosis induction, secondary metabolic
intermediates, depletion and chloride channel conductance
alterations. In the other context, Liu et al. (2010) showed that
atorvastatin causes mevalonate deficiency that affects oxida-
tive phosphorylation and mitochondrial adenosine triphos-
phate production leading to the muscular metabolism
impairment inducing oxidative stress causing myotoxicity.
The current study shows that the concurrent use of cur-
cumin with atorvastatin leads to a marked improvement of
all biochemical, histopathological and ultrastructural abnor-
malities. Curcumin is an anti-inflammatory and an antioxidant
agent which modulates the oxidative stress manifestations of
atorvastatin in different types of muscles which are consistent
with results of Aggarwal and Harikumar (2009), which showed
that curcumin has inhibitory actions on any tissue injury medi-
ated by the inflammatory transcription factors, protein
kinases, oxidative stress and inflammation. In accordance with
Wei et al. (2012), our results confirmed that curcumin can
reduce the myocardial enzymes and inflammatory factors pre-
venting cardiac injury. Furthermore, curcumin benefits depend
on the decrease of the reactive oxygen species generation,
phosphorylation of c-Jun N-terminal kinase, p38 MAP kinase,
signal transducer and activator of transcription (STAT)-3 in
TNF-a-stimulated cells according to Avci et al. (2012). In addi-
tion, Manjunatha and Srinivasan (2007), reported that cur-
cumin has an antioxidant effect based on lipid peroxidation
modulation and the increase of antioxidant enzymes activity
because it reverses glutathione depletion which is consistent
with our results. It should also be noted that the antioxidantPlease cite this article in press as: Elshama, S.S. et al., Curcumin modulates myotoxi
and biochemical analysis. Saudi Pharmaceutical Journal (2016), http://dx.doi.org/10effects of curcumin increase the serum MMP-13 levels that
are responsible for the restoration of normal collagen distribu-
tion in the muscles in agreement with Pinlaor et al. (2010).
5. Conclusion
In conclusion, sub-chronic use of atorvastatin may lead to
myotoxicity that is manifested by biochemical abnormalities,
and histopathological and ultrastructural changes in the differ-
ent types of rat muscles. Curcumin as an antioxidant may
modulate atorvastatin-induced myotoxicity. Further research
in humans is recommended in order to verify our results.
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